Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Lippman

Showing results (441-450 of 551) with videos related to

Pageof 56
Sort By:
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Cancer Discovery|February 12, 2017
Interaction Landscape of Inherited Polymorphisms with Somatic Events in CancerHannah Carter, Rachel Marty, Matan Hofree, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of the National Cancer Institute|April 5, 2018
Met Receptor Tyrosine Kinase and Chemoprevention of Oral CancerPierre Saintigny, William N William, Jean-Philippe Foy, et al.
Oral Oncology|March 5, 2015
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinomaSharat C Raju, Samantha J Hauff, Aaron J Lemieux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Pageof 56

Showing results (441-450 of 551) with videos related to

Sort By:
Pageof 56
Cancer Prevention Research (Philadelphia, Pa.)|January 14, 2009
Cyclin D1 and cancer development in laryngeal premalignancy patientsVassiliki Papadimitrakopoulou, Julie G Izzo, Diane D Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 17, 1998
Adenovirus-mediated p53 gene transfer in patients with advanced recurrent head and neck squamous cell carcinomaG L Clayman, A K el-Naggar, S M Lippman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 12, 2002
Phase II and biologic study of interferon alfa, retinoic acid, and cisplatin in advanced squamous skin cancerDong M Shin, Bonnie S Glisson, Fadlo R Khuri, et al.
Clinical Pharmacology and Therapeutics|April 24, 2014
Inflammation-related genetic variations and survival in patients with advanced non-small cell lung cancer receiving first-line chemotherapyXia Pu, Michelle A Hildebrandt, Charles Lu, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 8, 2001
The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trialF R Khuri, E S Kim, J J Lee, et al.
Cancer Discovery|February 12, 2017
Interaction Landscape of Inherited Polymorphisms with Somatic Events in CancerHannah Carter, Rachel Marty, Matan Hofree, et al.
Cancer|November 6, 2003
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinomaVassiliki A Papadimitrakopoulou, Lawrence E Ginsberg, Adam S Garden, et al.
Journal of the National Cancer Institute|April 5, 2018
Met Receptor Tyrosine Kinase and Chemoprevention of Oral CancerPierre Saintigny, William N William, Jean-Philippe Foy, et al.
Oral Oncology|March 5, 2015
Combined TP53 mutation/3p loss correlates with decreased radiosensitivity and increased matrix-metalloproteinase activity in head and neck carcinomaSharat C Raju, Samantha J Hauff, Aaron J Lemieux, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 8, 2026
Investigation of Profile-Related Evidence Determining Individualized Cancer Therapy (I-PREDICT) N-of-1 Precision Oncology Study: Molecular Profiling to Match Individually Dosed, Personalized Drug CombinationsJason K Sicklick, Daisuke Nishizaki, Hirotaka Miyashita, et al.
Pageof 56